UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 14, 2022
Accession Number:
0001193125-22-072315
Submission Type:
POS AM
CIK:
0001816736
Company Name:
Gemini Therapeutics, Inc. /DE
File Number:
333-253175